taurine has been researched along with Anxiety in 21 studies
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic amphetamine use results in anxiety-like states after drug cessation." | 7.79 | The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats. ( Gibula-Bruzda, E; Koltunowska, D; Kotlinska, JH, 2013) |
| "Taurine (TAU) is a β-amino sulfonic acid with pleiotropic roles in the brain, including the neuromodulatory activity via GABAergic and glycinergic agonism." | 5.56 | Concomitant taurine exposure counteracts ethanol-induced changes in locomotor and anxiety-like responses in zebrafish. ( Canzian, J; Duarte, T; Fontana, BD; Mezzomo, NJ; Müller, TE; Parker, MO; Rosemberg, DB; Ziani, PR, 2020) |
| "Taurine treatment significantly restored the HOT to WT levels of anxiety-like behavior in the elevated plus maze." | 5.51 | Taurine Partially Improves Abnormal Anxiety in Taurine-Deficient Mice. ( Chadman, KK; Elidrissi, A; Park, E; Schuller-Levis, G, 2019) |
| "Taurine (TAU) is an amino sulfonic acid with several functions in central nervous system." | 5.43 | The role of taurine on anxiety-like behaviors in zebrafish: A comparative study using the novel tank and the light-dark tasks. ( Giuliani, GS; Mezzomo, NJ; Quadros, VA; Rosemberg, DB; Silveira, A, 2016) |
| "Taurine has a variety of actions in the body such as cardiotonic, host-defensive, radioprotective and glucose-regulatory effects." | 5.34 | Taurine induces anti-anxiety by activating strychnine-sensitive glycine receptor in vivo. ( Kim, SJ; Zhang, CG, 2007) |
| "The combination of acamprosate and escitalopram suppressed EtOH intake in both nonstressed and stressed mice; hence, this combination is potentially helpful for AUD individuals with or without comorbid depression to reduce alcohol use." | 3.83 | Combined Effects of Acamprosate and Escitalopram on Ethanol Consumption in Mice. ( Aguiar, FS; Choi, DS; Hinton, DJ; Ho, AM; Jia, YF; Karpyak, VM; Qiu, Y; Weinshilboum, RM, 2016) |
| "Chronic amphetamine use results in anxiety-like states after drug cessation." | 3.79 | The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats. ( Gibula-Bruzda, E; Koltunowska, D; Kotlinska, JH, 2013) |
| "Acamprosate is a proven effective intervention in the treatment of alcohol dependence." | 2.43 | Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients. ( Geerlings, PJ; Koeter, MW; Lehert, P; van den Brink, W; Verheul, R, 2005) |
| "Taurine (TAU) is an amino sulfonic acid that plays protective roles against neurochemical impairments induced by ethanol (EtOH)." | 1.38 | Behavioral effects of taurine pretreatment in zebrafish acutely exposed to ethanol. ( Blaser, RE; Braga, MM; Calcagnotto, ME; Campos, MM; Córdova, SD; de Oliveira, DL; Dias, RD; Leite, CE; Loss, CM; Mussulini, BH; Rico, EP; Rosemberg, DB; Souza, DO, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Park, E | 1 |
| Elidrissi, A | 1 |
| Schuller-Levis, G | 1 |
| Chadman, KK | 1 |
| Fontana, BD | 1 |
| Duarte, T | 1 |
| Müller, TE | 2 |
| Canzian, J | 2 |
| Ziani, PR | 1 |
| Mezzomo, NJ | 2 |
| Parker, MO | 1 |
| Rosemberg, DB | 4 |
| Jangra, A | 1 |
| Rajput, P | 1 |
| Dwivedi, DK | 1 |
| Lahkar, M | 1 |
| Stefanello, FV | 1 |
| Franscescon, F | 1 |
| Quadros, VA | 2 |
| Souza, TP | 1 |
| Leitemperger, J | 1 |
| Loro, VL | 1 |
| Strasser, A | 1 |
| Xin, L | 1 |
| Gruetter, R | 1 |
| Sandi, C | 1 |
| Koltunowska, D | 1 |
| Gibula-Bruzda, E | 1 |
| Kotlinska, JH | 1 |
| Francisco, Eda S | 1 |
| Guedes, RC | 1 |
| Silveira, A | 1 |
| Giuliani, GS | 1 |
| Ho, AM | 1 |
| Qiu, Y | 1 |
| Jia, YF | 1 |
| Aguiar, FS | 1 |
| Hinton, DJ | 1 |
| Karpyak, VM | 1 |
| Weinshilboum, RM | 1 |
| Choi, DS | 1 |
| Kotlinska, J | 1 |
| Bochenski, M | 1 |
| El Idrissi, A | 1 |
| Boukarrou, L | 1 |
| Heany, W | 1 |
| Malliaros, G | 1 |
| Sangdee, C | 1 |
| Neuwirth, L | 1 |
| Umhau, JC | 1 |
| Schwandt, ML | 1 |
| Usala, J | 1 |
| Geyer, C | 1 |
| Singley, E | 1 |
| George, DT | 1 |
| Heilig, M | 1 |
| Braga, MM | 1 |
| Rico, EP | 1 |
| Loss, CM | 1 |
| Córdova, SD | 1 |
| Mussulini, BH | 1 |
| Blaser, RE | 1 |
| Leite, CE | 1 |
| Campos, MM | 1 |
| Dias, RD | 1 |
| Calcagnotto, ME | 1 |
| de Oliveira, DL | 1 |
| Souza, DO | 1 |
| Verheul, R | 1 |
| Lehert, P | 1 |
| Geerlings, PJ | 1 |
| Koeter, MW | 1 |
| van den Brink, W | 1 |
| Sher, L | 1 |
| Kong, WX | 1 |
| Chen, SW | 1 |
| Li, YL | 1 |
| Zhang, YJ | 1 |
| Wang, R | 1 |
| Min, L | 1 |
| Mi, X | 1 |
| Morley, KC | 1 |
| Teesson, M | 1 |
| Reid, SC | 1 |
| Sannibale, C | 1 |
| Thomson, C | 1 |
| Phung, N | 1 |
| Weltman, M | 1 |
| Bell, JR | 1 |
| Richardson, K | 1 |
| Haber, PS | 1 |
| McCool, BA | 1 |
| Chappell, A | 1 |
| Zhang, CG | 1 |
| Kim, SJ | 1 |
| Acosta, GB | 1 |
| Cole, JC | 1 |
| Littleton, JM | 1 |
| Little, HJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Efficacy and Tolerance of B-Back® on the Burnout Syndrome. Double-blind, Randomized, Monocentric Trial With Two Parallel Groups (B-Back® Verum Versus B-Back® Placebo)[NCT01599169] | 87 participants (Actual) | Interventional | 2012-05-31 | Completed | |||
| Phase Four Randomized, Multicentre, Open-Label, Comparative Trial Of Disulfiram, Nalterexone And Acamprosate In The Treatment Of Alcohol Dependence[NCT00435435] | Phase 4 | 243 participants | Interventional | 2000-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for taurine and Anxiety
| Article | Year |
|---|---|
Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
Topics: Acamprosate; Adult; Age Factors; Aged; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Anxiety; Do | 2005 |
Alcoholism and suicidal behavior: a clinical overview.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents, Tricyclic; Anxiety; Comorbidity; | 2006 |
2 trials available for taurine and Anxiety
| Article | Year |
|---|---|
Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate.
Topics: Acamprosate; Adrenergic alpha-2 Receptor Antagonists; Adult; Alcohol Deterrents; Alcohol-Induced Dis | 2011 |
Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol-Related Disorders; Anxiety; Australia; Depressive Di | 2006 |
17 other studies available for taurine and Anxiety
| Article | Year |
|---|---|
Taurine Partially Improves Abnormal Anxiety in Taurine-Deficient Mice.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Mice; Mice, Knockout; Taurine | 2019 |
Concomitant taurine exposure counteracts ethanol-induced changes in locomotor and anxiety-like responses in zebrafish.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Brain; Dose-Response Relationship, Drug; Ethanol; Female; Loc | 2020 |
Amelioration of Repeated Restraint Stress-Induced Behavioral Deficits and Hippocampal Anomalies with Taurine Treatment in Mice.
Topics: Acetylcholinesterase; Animals; Anxiety; Behavior, Animal; Depression; Hippocampus; Interleukin-1beta | 2020 |
Taurine modulates behavioral effects of intermittent ethanol exposure without changing brain monoamine oxidase activity in zebrafish: Attenuation of shoal- and anxiety-like responses, and abolishment of memory acquisition deficit.
Topics: Animals; Anxiety; Behavior, Animal; Brain; Disease Models, Animal; Ethanol; Female; Humans; Male; Me | 2021 |
Nucleus accumbens neurochemistry in human anxiety: A 7 T
Topics: Adult; Anxiety; Aspartic Acid; Correlation of Data; Female; gamma-Aminobutyric Acid; Glutamic Acid; | 2019 |
The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats.
Topics: Acamprosate; Amphetamine; Animals; Anxiety; Bridged Bicyclo Compounds; Dose-Response Relationship, D | 2013 |
Neonatal taurine and alanine modulate anxiety-like behavior and decelerate cortical spreading depression in rats previously suckled under different litter sizes.
Topics: Alanine; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Cortical Spreading Depression; Litter | 2015 |
The role of taurine on anxiety-like behaviors in zebrafish: A comparative study using the novel tank and the light-dark tasks.
Topics: Animals; Anxiety; Avoidance Learning; Darkness; Light; Motor Activity; Taurine; Zebrafish | 2016 |
Combined Effects of Acamprosate and Escitalopram on Ethanol Consumption in Mice.
Topics: Acamprosate; Alcohol Drinking; Animals; Anxiety; Citalopram; Depression; Drug Therapy, Combination; | 2016 |
The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
Topics: Acamprosate; Alcohol Deterrents; Animals; Anxiety; Behavior, Animal; Central Nervous System Depressa | 2008 |
Effects of taurine on anxiety-like and locomotor behavior of mice.
Topics: Animals; Anxiety; Locomotion; Maze Learning; Mice; Motor Activity; Taurine | 2009 |
Behavioral effects of taurine pretreatment in zebrafish acutely exposed to ethanol.
Topics: Alcoholic Intoxication; Animals; Anxiety; Behavior, Animal; Brain; Dietary Supplements; Disease Mode | 2012 |
Effects of taurine on rat behaviors in three anxiety models.
Topics: Animals; Anxiety; Behavior, Animal; Interpersonal Relations; Male; Maze Learning; Rats; Rats, Wistar | 2006 |
Strychnine and taurine modulation of amygdala-associated anxiety-like behavior is 'state' dependent.
Topics: Affect; Amygdala; Analysis of Variance; Animals; Anxiety; Avoidance Learning; Chloride Channels; Env | 2007 |
Taurine induces anti-anxiety by activating strychnine-sensitive glycine receptor in vivo.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Exercise Test; Exploratory Behavior; Male | 2007 |
Administration of cholecystokinin sulphated octapeptide (CCK-8S) induces changes on rat amino acid tissue levels and on a behavioral test for anxiety.
Topics: Alanine; Amino Acids; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Brain; Cerebral Corte | 1998 |
Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze.
Topics: Acamprosate; Alcohol Deterrents; Animals; Anxiety; Central Nervous System Depressants; Ethanol; Expl | 2000 |